Short answer
ORTHOPEDIATRICS CORP (KIDS) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $71M (up 15.4% year over year) with net income of −$7M.
Q2 2026 key financials · XBRL
- Revenue
- $71M
- +15.4% YoY · +18.8% QoQ
- Net income
- −$7M
- −0.7% YoY · +33.0% QoQ
- Operating margin
- -5.8%
- Gross margin
- 74.3%
- EPS (diluted)
- −$0.30
- +0.0% YoY · +33.3% QoQ
Source: XBRL data from the ORTHOPEDIATRICS CORP (KIDS) Q2 2026 10-Q on SEC EDGAR. USD.
ORTHOPEDIATRICS CORP Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes to risk factors since March 4, 2026 Form 10-K
- Regulatory risk: UK distributor acquisition involved 80,873 unregistered shares issued under Section 4(a)(2)
- Acquisition integration risk: UK medical-device distributor purchased for $1,398,666 in stock
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORTHOPEDIATRICS CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.